BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25300170)

  • 21. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR (252)Cf or HDR (60)Co intracavitary brachytherapy.
    Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
    Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
    Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transition from LDR to HDR brachytherapy for cervical cancer: Evaluation of tumor control, survival, and toxicity.
    Romano KD; Pugh KJ; Trifiletti DM; Libby B; Showalter TN
    Brachytherapy; 2017; 16(2):378-386. PubMed ID: 28139420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status and perspectives of brachytherapy for cervical cancer.
    Toita T
    Int J Clin Oncol; 2009 Feb; 14(1):25-30. PubMed ID: 19225920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.
    Gupta IJ; Ghosh A; Yadav J; Tuteja JS; Gupta R; Srivastava K; Verma M; Gupta S; Srivastava S; Bhatt MLB
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3441-3445. PubMed ID: 37898849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
    Bennett MH; Feldmeier J; Smee R; Milross C
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD005007. PubMed ID: 29637538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma.
    Sarkaria JN; Petereit DG; Stitt JA; Hartman T; Chappell R; Thomadsen BR; Buchler DA; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):75-82; discussion 247. PubMed ID: 8083131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
    Stewart AJ; Viswanathan AN
    Cancer; 2006 Sep; 107(5):908-15. PubMed ID: 16874815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative radiation for cervical cancer with pathologic risk factors.
    Hart K; Han I; Deppe G; Malviya V; Malone J; Christensen C; Chuba P; Porter A
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):833-8. PubMed ID: 9128959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial.
    Hareyama M; Sakata K; Oouchi A; Nagakura H; Shido M; Someya M; Koito K
    Cancer; 2002 Jan; 94(1):117-24. PubMed ID: 11815967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
    Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study.
    el-Baradie M; Inoue T; Inoue T; Murayama S; Tang JT; Yamazaki H; Fournier-Bidoz N
    Strahlenther Onkol; 1997 Mar; 173(3):155-62. PubMed ID: 9122857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.
    Chuai Y; Rizzuto I; Zhang X; Li Y; Dai G; Otter SJ; Bharathan R; Stewart A; Wang A
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013348. PubMed ID: 33661538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer.
    Lee HJ; Kim YS; Shin SS; Nam JH; Kim YT; Han S; Choi EK
    Tumori; 2012; 98(5):615-21. PubMed ID: 23235757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience.
    Okkan S; Atkovar G; Sahinler I; Oner Dinçbaş F; Koca A; Köksal S; Turkan S; Uzel R
    Radiother Oncol; 2003 Apr; 67(1):97-105. PubMed ID: 12758245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T
    Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A regional cooperative clinical study of radiotherapy for cervical cancer in east and south-east Asian countries.
    Nakano T; Kato S; Cao J; Zhou J; Susworo R; Supriana N; Sato S; Ohno T; Suto H; Nakamura Y; Cho CK; Ismail FB; Calaguas MJ; de Los Reyes RH; Chansilpa Y; Thephamongkhol K; Duc NB; Dung TA; Tsujii H
    Radiother Oncol; 2007 Sep; 84(3):314-9. PubMed ID: 17532495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Lahousen M; Hackl A
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):531-40. PubMed ID: 9806511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.